American Oriental Bioengineering, Inc.
AOBI
Rank in Stocks
#34995
American Oriental Bioengineering, Inc. (AOBI), headquartered in Beijing, China,... American Oriental Bioengineering, Inc. (AOBI), headquartered in Beijing, China, focuses its operations on the development, manufacturing, and commercialization of a broad spectrum of pharmaceutical and healthcare products. The company's core pharmaceutical offerings include a range of prescription medications. Among these are the Shuanghuanglian Lyophilized Injection Powder (SHL brand), prescribed to treat flu symptoms such as elevated fever, coughs, and sore throats, as well as to address upper respiratory tract infections, mild pneumonia, bronchitis, and tonsillitis. Another significant prescription product is the Cease Enuresis Soft Gel (CE Gel brand), formulated to alleviate bedwetting. AOBI's portfolio also extends to various over-the-counter (OTC) pharmaceutical solutions. These feature the Cease Enuresis Patch for managing bedwetting and urinary incontinence; Jinji Capsule, used for conditions like endometritis, annexitis, and pelvic inflammations; Jinji Yimucao, designed to relieve premenstrual syndrome (PMS) and other related menstrual and menopausal discomforts; and Boke Nasal Spray, which offers relief for sinus congestion associated with the common cold, nasal stuffiness, chronic rhinitis, allergic rhinitis, and nasosinusitis. Furthermore, the company develops and markets a selection of nutraceutical products, notably including soybean peptide-based items available as beverages, tablets, powders, and instant coffee. Beyond its manufacturing activities, AOBI is also involved in the wholesale and retail distribution of both its pharmaceutical and nutraceutical goods. The company's products are sold across the People's Republic of China through both direct channels and a network of distributors, reaching hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical retailers, and various other retail outlets.
Share Price
$0.013
Last synced: 2026-11-10
Market Cap
$948.13
Change (1 day)
0.00%
Change (1 year)
983.33%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade American Oriental Bioengineering, Inc. (AOBI)
Category
Healthcare
EPS for American Oriental Bioengineering, Inc. (AOBI)
EPS as of September 2013 TTM: $-1.24K
According to American Oriental Bioengineering, Inc.'s latest financial reports, its current EPS (TTM) is $-1.24K. At the end of 2012 the company had an EPS of $-781.24, an increase over its 2011 EPS of $-901.80.
EPS history for American Oriental Bioengineering, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.24K | 58.85% |
| 2012 | $-781.24 | -13.37% |
| 2011 | $-901.80 | -573.68% |
| 2010 | $190.38 | -82.88% |
| 2009 | $1.11K | 79.03% |
| 2008 | $621.24 | 0.00% |
| 2007 | $621.24 | 31.91% |
| 2006 | $470.94 | 51.61% |
| 2005 | $310.62 | 34.78% |
| 2004 | $230.46 | 53.33% |
| 2003 | $150.30 | 36.36% |
| 2002 | $110.22 | -15.38% |
| 2001 | $130.26 | -107.75% |
| 2000 | $-1.68K | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -101.26% |
US
|
|
| $-7.07 | -99.43% |
US
|
|
| $-5.29 | -99.57% |
AU
|
|
| $12.88 | -101.04% |
BE
|
|
| $21.56 | -101.74% |
NL
|
Questions about American Oriental Bioengineering, Inc.'s earnings per share (EPS)
What is American Oriental Bioengineering, Inc.'s earnings per share (EPS)?
American Oriental Bioengineering, Inc.'s earnings per share (EPS) over the last twelve months is $-1.24K, as of Sep 2013.
What was American Oriental Bioengineering, Inc.'s earnings per share (EPS) in 2012?
In 2012, American Oriental Bioengineering, Inc.'s earnings per share (EPS) was $-781.24, compared with $-901.80 in 2011.
How has American Oriental Bioengineering, Inc.'s earnings per share (EPS) changed since 2007?
From 2007 to 2012, American Oriental Bioengineering, Inc.'s earnings per share (EPS) was highest in 2009 ($1.11K) and lowest in 2011 ($-901.80).
How does American Oriental Bioengineering, Inc.'s earnings per share (EPS) compare with similar companies?
American Oriental Bioengineering, Inc.'s earnings per share (EPS) ($-1.24K) is lower than that of all 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.